Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia

Shunsuke Uno, Ryota Hase, Masayoshi Kobayashi, Toshiyasu Shiratori, So Nakaji, Nobuto Hirata, Naoto Hosokawa

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives The optimal antimicrobial treatment duration for patients with acute cholangitis with bacteremia remains unknown. The updated Tokyo Guidelines 2013 recommend a minimum duration of 2 weeks only when bacteremia with Gram-positive cocci is present. Since May 2013, a shorter antimicrobial treatment duration of under 2 weeks has been implemented at the authors’ institution for acute cholangitis with Gram-negative bacillary bacteremia. The aim of the present study was to validate this modified practice. Methods A single-center retrospective cohort study was conducted. The antimicrobial treatment duration, 30-day mortality rate, and recurrence rate within 3 months were compared between patients treated before May 2013 and after May 2013. Results Ninety-one patients with cholangitis with bacteremia were analyzed. The median antimicrobial treatment duration was 14.5 days in patients treated before May 2013 and 10.0 days after May 2013 (p < 0.001). While the 30-day mortality rate did not differ significantly, the recurrence rate was higher in those treated before May 2013 (5.7% vs. 0.0%, p = 0.17 and 13.3% vs. 0.0%, p = 0.03, respectively). The median treatment duration after May 2013 was 8 days for grade I patients, 10 days for grade II patients, and 11.5 days for grade III patients. Conclusions The results of this study suggest that acute cholangitis with Gram-negative bacillary bacteremia can be treated safely with a shorter antimicrobial treatment duration of <14 days.

Original languageEnglish
Pages (from-to)81-85
Number of pages5
JournalInternational Journal of Infectious Diseases
Volume55
DOIs
Publication statusPublished - 2017 Feb 1

Fingerprint

Cholangitis
Bacteremia
Therapeutics
Recurrence
Gram-Positive Cocci
Mortality
Tokyo
Cohort Studies
Retrospective Studies
Guidelines

Keywords

  • Acute cholangitis
  • Antimicrobial stewardship
  • Bacteremia
  • Drainage

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. / Uno, Shunsuke; Hase, Ryota; Kobayashi, Masayoshi; Shiratori, Toshiyasu; Nakaji, So; Hirata, Nobuto; Hosokawa, Naoto.

In: International Journal of Infectious Diseases, Vol. 55, 01.02.2017, p. 81-85.

Research output: Contribution to journalArticle

Uno, Shunsuke ; Hase, Ryota ; Kobayashi, Masayoshi ; Shiratori, Toshiyasu ; Nakaji, So ; Hirata, Nobuto ; Hosokawa, Naoto. / Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia. In: International Journal of Infectious Diseases. 2017 ; Vol. 55. pp. 81-85.
@article{a77e4a32b5ec415581054070eb40a294,
title = "Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia",
abstract = "Objectives The optimal antimicrobial treatment duration for patients with acute cholangitis with bacteremia remains unknown. The updated Tokyo Guidelines 2013 recommend a minimum duration of 2 weeks only when bacteremia with Gram-positive cocci is present. Since May 2013, a shorter antimicrobial treatment duration of under 2 weeks has been implemented at the authors’ institution for acute cholangitis with Gram-negative bacillary bacteremia. The aim of the present study was to validate this modified practice. Methods A single-center retrospective cohort study was conducted. The antimicrobial treatment duration, 30-day mortality rate, and recurrence rate within 3 months were compared between patients treated before May 2013 and after May 2013. Results Ninety-one patients with cholangitis with bacteremia were analyzed. The median antimicrobial treatment duration was 14.5 days in patients treated before May 2013 and 10.0 days after May 2013 (p < 0.001). While the 30-day mortality rate did not differ significantly, the recurrence rate was higher in those treated before May 2013 (5.7{\%} vs. 0.0{\%}, p = 0.17 and 13.3{\%} vs. 0.0{\%}, p = 0.03, respectively). The median treatment duration after May 2013 was 8 days for grade I patients, 10 days for grade II patients, and 11.5 days for grade III patients. Conclusions The results of this study suggest that acute cholangitis with Gram-negative bacillary bacteremia can be treated safely with a shorter antimicrobial treatment duration of <14 days.",
keywords = "Acute cholangitis, Antimicrobial stewardship, Bacteremia, Drainage",
author = "Shunsuke Uno and Ryota Hase and Masayoshi Kobayashi and Toshiyasu Shiratori and So Nakaji and Nobuto Hirata and Naoto Hosokawa",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.ijid.2016.12.018",
language = "English",
volume = "55",
pages = "81--85",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia

AU - Uno, Shunsuke

AU - Hase, Ryota

AU - Kobayashi, Masayoshi

AU - Shiratori, Toshiyasu

AU - Nakaji, So

AU - Hirata, Nobuto

AU - Hosokawa, Naoto

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Objectives The optimal antimicrobial treatment duration for patients with acute cholangitis with bacteremia remains unknown. The updated Tokyo Guidelines 2013 recommend a minimum duration of 2 weeks only when bacteremia with Gram-positive cocci is present. Since May 2013, a shorter antimicrobial treatment duration of under 2 weeks has been implemented at the authors’ institution for acute cholangitis with Gram-negative bacillary bacteremia. The aim of the present study was to validate this modified practice. Methods A single-center retrospective cohort study was conducted. The antimicrobial treatment duration, 30-day mortality rate, and recurrence rate within 3 months were compared between patients treated before May 2013 and after May 2013. Results Ninety-one patients with cholangitis with bacteremia were analyzed. The median antimicrobial treatment duration was 14.5 days in patients treated before May 2013 and 10.0 days after May 2013 (p < 0.001). While the 30-day mortality rate did not differ significantly, the recurrence rate was higher in those treated before May 2013 (5.7% vs. 0.0%, p = 0.17 and 13.3% vs. 0.0%, p = 0.03, respectively). The median treatment duration after May 2013 was 8 days for grade I patients, 10 days for grade II patients, and 11.5 days for grade III patients. Conclusions The results of this study suggest that acute cholangitis with Gram-negative bacillary bacteremia can be treated safely with a shorter antimicrobial treatment duration of <14 days.

AB - Objectives The optimal antimicrobial treatment duration for patients with acute cholangitis with bacteremia remains unknown. The updated Tokyo Guidelines 2013 recommend a minimum duration of 2 weeks only when bacteremia with Gram-positive cocci is present. Since May 2013, a shorter antimicrobial treatment duration of under 2 weeks has been implemented at the authors’ institution for acute cholangitis with Gram-negative bacillary bacteremia. The aim of the present study was to validate this modified practice. Methods A single-center retrospective cohort study was conducted. The antimicrobial treatment duration, 30-day mortality rate, and recurrence rate within 3 months were compared between patients treated before May 2013 and after May 2013. Results Ninety-one patients with cholangitis with bacteremia were analyzed. The median antimicrobial treatment duration was 14.5 days in patients treated before May 2013 and 10.0 days after May 2013 (p < 0.001). While the 30-day mortality rate did not differ significantly, the recurrence rate was higher in those treated before May 2013 (5.7% vs. 0.0%, p = 0.17 and 13.3% vs. 0.0%, p = 0.03, respectively). The median treatment duration after May 2013 was 8 days for grade I patients, 10 days for grade II patients, and 11.5 days for grade III patients. Conclusions The results of this study suggest that acute cholangitis with Gram-negative bacillary bacteremia can be treated safely with a shorter antimicrobial treatment duration of <14 days.

KW - Acute cholangitis

KW - Antimicrobial stewardship

KW - Bacteremia

KW - Drainage

UR - http://www.scopus.com/inward/record.url?scp=85010447539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010447539&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2016.12.018

DO - 10.1016/j.ijid.2016.12.018

M3 - Article

C2 - 28027992

AN - SCOPUS:85010447539

VL - 55

SP - 81

EP - 85

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -